Compare XBIT & III Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XBIT | III |
|---|---|---|
| Founded | 2005 | 2006 |
| Country | United States | United States |
| Employees | N/A | 1500 |
| Industry | Pharmaceuticals and Biotechnology | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.3M | 250.9M |
| IPO Year | 2015 | 2006 |
| Metric | XBIT | III |
|---|---|---|
| Price | $2.39 | $3.89 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.50 |
| AVG Volume (30 Days) | 26.8K | ★ 259.8K |
| Earning Date | 03-13-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 4.60% |
| EPS Growth | N/A | ★ 216.67 |
| EPS | N/A | ★ 0.19 |
| Revenue | N/A | ★ $192,745,000.00 |
| Revenue This Year | N/A | $4.62 |
| Revenue Next Year | N/A | $5.22 |
| P/E Ratio | ★ N/A | $20.47 |
| Revenue Growth | N/A | ★ 4.51 |
| 52 Week Low | $2.09 | $3.43 |
| 52 Week High | $3.62 | $6.45 |
| Indicator | XBIT | III |
|---|---|---|
| Relative Strength Index (RSI) | 53.75 | 27.62 |
| Support Level | $2.32 | N/A |
| Resistance Level | $2.49 | $6.06 |
| Average True Range (ATR) | 0.10 | 0.18 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 74.60 | 11.50 |
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
Information Services Group Inc is a U.S.-based technology insight, market intelligence, and advisory services firm. It principally offers digital transformation services, such as automation and cloud & data analytics; managed governance; network carrier services; technology plan and operations design; changes management; market intelligence & technology research and analysis. It operates in one segment, fact-based sourcing advisory services. Its geographical segments are the Americas, Europe, and Asia-pacific, out of which maximum revenue is derived from Americas.